Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, ÓXIDO NÍTRICO, CANAIS IÔNICOS, POTÁSSIO, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Camila A. et al. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, v. 765, p. 375–383, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2015.09.002. Acesso em: 07 nov. 2024.APA
Pereira, C. A., Ferreira, N. dos S., Mestriner, F. L. A. C., Antunes-Rodrigues, J., Évora, P. R. B., Resstel, L. B. M., et al. (2015). Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, 765, 375–383. doi:10.1016/j.ejphar.2015.09.002NLM
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002Vancouver
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002
